Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terri Brown

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
The Journal of Allergy and Clinical Immunology. in Practice|April 18, 2026
Age-Appropriate Low Dosing for FPIES Oral Food Challenges: Proposing a Standardized ApproachSara Anvari, Mary Grace Baker, Theresa Bingemann, et al.
The Journal of Allergy and Clinical Immunology|May 30, 2025
Introduction of allergenic foods after treatment with omalizumabJennifer Dantzer, Yamini Virkud, Julie Wang, et al.
The Journal of Allergy and Clinical Immunology|November 14, 2025
Exploratory analyses of predictors and correlates of response to omalizumab therapy in patients with multiple food allergiesR Sharon Chinthrajah, Michael Kulis, Stacie M Jones, et al.
Nature Medicine|July 23, 2013
Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitisMario Noti, Elia D Tait Wojno, Brian S Kim, et al.
The Journal of Allergy and Clinical Immunology|February 8, 2017
International consensus guidelines for the diagnosis and management of food protein-induced enterocolitis syndrome: Executive summary-Workgroup Report of the Adverse Reactions to Foods Committee, American Academy of Allergy, Asthma & ImmunologyAnna Nowak-Węgrzyn, Mirna Chehade, Marion E Groetch, et al.
The New England Journal of Medicine|February 26, 2024
Omalizumab for the Treatment of Multiple Food AllergiesRobert A Wood, Alkis Togias, Scott H Sicherer, et al.
The Journal of Allergy and Clinical Immunology|July 14, 2020
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year resultsDavid M Fleischer, Wayne G Shreffler, Dianne E Campbell, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 16, 2025
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPEMatthew Greenhawt, Deborah Albright, Sara Anvari, et al.
The New England Journal of Medicine|May 10, 2023
Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut AllergyMatthew Greenhawt, Sayantani B Sindher, Julie Wang, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The Journal of Allergy and Clinical Immunology. in Practice|April 18, 2026
Age-Appropriate Low Dosing for FPIES Oral Food Challenges: Proposing a Standardized ApproachSara Anvari, Mary Grace Baker, Theresa Bingemann, et al.
The Journal of Allergy and Clinical Immunology|May 30, 2025
Introduction of allergenic foods after treatment with omalizumabJennifer Dantzer, Yamini Virkud, Julie Wang, et al.
The Journal of Allergy and Clinical Immunology|November 14, 2025
Exploratory analyses of predictors and correlates of response to omalizumab therapy in patients with multiple food allergiesR Sharon Chinthrajah, Michael Kulis, Stacie M Jones, et al.
Nature Medicine|July 23, 2013
Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitisMario Noti, Elia D Tait Wojno, Brian S Kim, et al.
The Journal of Allergy and Clinical Immunology|February 8, 2017
International consensus guidelines for the diagnosis and management of food protein-induced enterocolitis syndrome: Executive summary-Workgroup Report of the Adverse Reactions to Foods Committee, American Academy of Allergy, Asthma & ImmunologyAnna Nowak-Węgrzyn, Mirna Chehade, Marion E Groetch, et al.
The New England Journal of Medicine|February 26, 2024
Omalizumab for the Treatment of Multiple Food AllergiesRobert A Wood, Alkis Togias, Scott H Sicherer, et al.
The Journal of Allergy and Clinical Immunology|July 14, 2020
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year resultsDavid M Fleischer, Wayne G Shreffler, Dianne E Campbell, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 16, 2025
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPEMatthew Greenhawt, Deborah Albright, Sara Anvari, et al.
The New England Journal of Medicine|May 10, 2023
Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut AllergyMatthew Greenhawt, Sayantani B Sindher, Julie Wang, et al.
Pageof 4